Insider Stock Trading History of Riedel Norbert G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Riedel Norbert G since year 2005. The trader's CIK number is 1161662. At the time of this reporting, Riedel Norbert G is the Director of Eton Pharmaceuticals, Inc. . (stock ticker symbol ETON). See this page for all insider trading activities at Eton Pharmaceuticals, Inc. .

Note that in the past RIEDEL NORBERT G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Riedel Norbert G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-11-15 ETON Eton Pharmaceuticals, Inc. Buy 5,000 6.00 30,000
2018-11-12 APTX Aptinyx Inc. Option Ex 38,563 2.59 99,878
2018-08-10 JAZZ Jazz Pharmaceuticals Plc Sale 660 176.61 116,563
2018-06-25 APTX Aptinyx Inc. Buy 2,400 16.00 38,400
2017-08-11 JAZZ Jazz Pharmaceuticals Plc Sale 662 143.25 94,828
2016-08-15 JAZZ Jazz Pharmaceuticals Plc Sale 633 136.45 86,372
2016-05-16 JAZZ Jazz Pharmaceuticals Plc Sale 644 145.20 93,508
2015-08-10 JAZZ Jazz Pharmaceuticals Plc Sale 801 181.67 145,517
2015-05-12 JAZZ Jazz Pharmaceuticals Plc Sale 650 174.47 113,408
2014-05-28 JAZZ Jazz Pharmaceuticals Plc Sale 644 142.49 91,763
2012-08-03 BAX Baxter International Inc Option Ex 70,125 38.35 2,689,293
2012-08-03 BAX Baxter International Inc Sale 70,125 58.99 4,136,673
2010-03-05 BAX Baxter International Inc Option Ex 75,600 49.54 3,745,224
2010-03-05 BAX Baxter International Inc Sale 75,600 59.29 4,482,324
2009-12-02 BAX Baxter International Inc Option Ex 92,500 30.99 2,866,575
2009-12-02 BAX Baxter International Inc Sale 92,500 55.92 5,172,600
2009-01-27 BAX Baxter International Inc Sale 80,000 58.09 4,647,200
2009-01-26 BAX Baxter International Inc Sale 22,300 58.00 1,293,400
2009-01-27 BAX Baxter International Inc Option Ex 80,000 41.34 3,307,200
2009-01-26 BAX Baxter International Inc Option Ex 22,300 41.34 921,882
2007-06-05 BAX Baxter International Inc Option Ex 54,584 30.76 1,678,785
2007-06-06 BAX Baxter International Inc Option Ex 39,700 28.59 1,135,221
2007-06-05 BAX Baxter International Inc Sale 54,584 57.54 3,140,545
2007-06-06 BAX Baxter International Inc Sale 39,700 57.40 2,278,780

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Riedel Norbert G (Director of Eton Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.